COLL Collegium Pharmaceutical, Inc.

NASDAQ
$22.53

Collegium Pharmaceutical, Inc. (COLL) is expected to report earnings on November 9, 2026, before the market open. The consensus earnings estimate is $1.58 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -28.9% since its last earnings release on August 6, 2026.

Collegium Pharmaceutical Beat Consensus Estimates, Lowers Guidance
Thursday, August 6, 2026 · 7:30 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 9
Monday · 7:30 AM ET
Earnings Whisper
-
vs $1.58
Rev est $215.35M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $25.30

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Collegium Pharmaceutical, Inc.

Collegium is a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions.

Sector

Healthcare

Industry

Drug Manufacturers/Other

Held By 6 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.